About
Dr. Arpit Jain is a dedicated Medical Oncologist and Consultant in the Department of Medical Oncology at Rajiv Gandhi Cancer Institute & Research Centre, New Delhi. He specializes in the diagnosis and systemic treatment of a wide range of cancers, with expertise in chemotherapy, immunotherapy, targeted therapy, and personalized cancer care.
He has extensive experience in the management of breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematological malignancies, and is committed to delivering evidence-based, compassionate, and individualized care to every patient.
Dr. Jain completed his DrNB in Medical Oncology from Rajiv Gandhi Cancer Institute & Research Centre and is also a European Certified Medical Oncologist (ECMO). Prior to this, he earned his MD in Radiation Oncology from Mahatma Gandhi Memorial Medical College, Indore.
Along with his clinical work, Dr. Jain is actively involved in clinical research, academic teaching, and international oncology collaborations. He has authored multiple peer-reviewed publications, contributed book chapters, and presented research at national and international oncology meetings including American Society of Clinical Oncology and European Society for Medical Oncology.
His approach focuses on combining the latest scientific advances with patient-centered care to provide the best possible treatment outcomes.
Professional Journey
Clinical Trial Participation (Sub-Investigator)
- Zanidatamab + SOC vs SOC in advanced HER2-positive biliary tract cancer (Phase III)
- CLARITY-Gastric 01 (Claudin18.2-positive gastric/GEJ cancer)
- ARTEMIDE-Biliary01
- Prospective metastatic colorectal cancer registry
- Real-world Indian urothelial carcinoma registry
- Metastatic prostate adenocarcinoma outcomes study
- Disitamab vedotin + pembrolizumab in HER2-positive urothelial carcinoma
Academic & Professional Achievements
- Faculty speaker and moderator at national oncology meetings
- Multiple oral and poster presentations at ASCO/ESMO/ESMO GI
- Active mentorship of fellows and resident academic programs
- Principal contributor to institutional GU/GI translational oncology datasets
- AI-assisted oncology outcomes and radiology-pathology concordance research
Awards
- Honored by NBE for research contribution in thoracic oncology molecular diagnostics (2022)
- Top academic performance during postgraduate training
- Multiple distinctions during MBBS
Research Interests
- GU oncology (urothelial / prostate / renal)
- Pancreaticobiliary oncology
- GI translational biomarkers / DPD deficiency / MSI
- Immunotherapy biomarkers and resistance
- Antibody–drug conjugates
- AI/LLM-assisted oncology clinical decision support
- Real-world evidence studies
Publication
Original Articles / Clinical Research
- Mukherjee A, Goyal P, Tripathi R, et al. Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India. PLoS One. 2026 May.
- Goel V, Jain A, Basu DA, et al. Clinical implications of dihydropyrimidine dehydrogenase deficiency in gastrointestinal and hepatopancreaticobiliary cancers treated with fluoropyrimidines: a prospective observational study. JCO Glob Oncol. 2025 Nov.
- Goel V, Jain A, Patnaik N, et al. Efficacy and safety of paclitaxel plus ramucirumab as second-line therapy in advanced gastric cancer: a retro-prospective single-centre study. Gulf J Oncol. 2025 Sep.
- Goel V, Jain A, Basu D, et al. FH-deficient uterine leiomyomas: pathological insights into a rare tumor. Gulf J Oncol. 2025 May.
- Jain A, Talwar V, Patnaik N, Jaju A, Goel V. Comparative efficacy and toxicity of gemcitabine-cisplatin versus gemcitabine-carboplatin in metastatic carcinoma urinary bladder: a retrospective review. Gulf J Oncol. 2025 Jul.
- Goel V, Jain A, Soni S, Singh S, Basu DA. Comparative efficacy and toxicity of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a real-world retrospective analysis. Cureus. 2025 Jul.
- Goel V, Jain A, Basu DA, Rawal S, Talwar V. A comparative study of gemcitabine-cisplatin versus dose-dense MVAC as neoadjuvant chemotherapy for muscle-invasive bladder cancer. Cureus. 2025 May.
- Batra U, Sharma M, Jain P, Nathany S, Jain A. Indian experience of afatinib for EGFR mutation-positive advanced lung adenocarcinoma: a real-world retrospective study. Indian J Cancer. 2025 Feb.
- Joga S, Goyal S, Mehta A, Doval DC, Jain A. Molecular subtypes of colorectal cancer and their correlation with clinicopathological profile in a tertiary care center in India. South Asian J Cancer. 2025 Jan.
- Jain A, Goel V, Soni S, Talwar V. Antibody-drug conjugates revolutionize urothelial carcinoma therapy. Curr Trends Intern Med. 2024 Jun.
- Goyal P, Mukherjee A, Tripathi R, Dewan A, Jain A. Real-world experience with cyclin-dependent kinase inhibitors in metastatic breast cancer from India. J Clin Oncol. 2024 Jun.
- Goyal P, Doval DC, Jain S, Basu DA, Jain A. Survival and safety analysis of eribulin in Indian patients with metastatic breast cancer: a real-world clinical experience. J Clin Oncol. 2024 Jun.
- Jain A, Soni S, Domadia KR, Goel V, Talwar V. Matched-pair analysis of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: survival and toxicity outcomes. Ann Oncol. 2024 Jun.
- Jain A, Goyal V, Soni S, Talwar V. Tumor regression grade in locally advanced rectal cancer post-neoadjuvant chemoradiotherapy: predictive and clinical implications. Ann Oncol. 2024 Jun.
- Soni S, Jain A, Goyal V, Goel V. Modified FOLFIRINOX in unresectable and metastatic pancreatic cancer: a single-center experience. Ann Pancreat Cancer. 2023 Nov.
- Jain A, Goyal V, Basu DA, Goel V. Disseminated intravascular coagulation as a rare presentation of metastatic prostate carcinoma. IP Arch Cytol Histopathol Res. 2023 Jul.
- Bansal N, Goyal P, Basu D, Doval DC, Jain A. Impact of improving infection control and antibiotic stewardship practices on nosocomial infections in an oncology centre in India. Indian J Med Microbiol. 2023 May.
- Goyal P, Joga S, Tripathi R, Doval DC, Jain A. Real-world experience with osteosarcoma in an Indian tertiary care centre. J Cancer Sci Clin Ther. 2023 Jan.
- Narayan S, Talwar V, Goel V, Jain A, Mehta A. Correlation of SARS-CoV-2-related 30-day mortality with HRCT score and RT-PCR Ct values in patients with cancer. World J Clin Oncol. 2022 May.
- Jain A, Joga S, Patel AB. Optimizing bevacizumab dose in glioblastoma: a cost-containment strategy. Cancer Res Stat Treat. 2021 Jul.
- Sharma M, Nathany S, Soni S, Jain A, Mehta A, Jain P, Batra U. BRAF mutations in Indian patients with NSCLC: a molecular kaleidoscope. J Clin Oncol. 2021 May.
- Jain A, Jaju A, Iyer M, Arya R, Jain P. Stomach metastasis from malignant melanoma: an unusual presentation. Indian J Pathol Oncol. 2020;7(3):480–482.
- Verma M, Jain A, Shivhare V, Singh AP. Concomitant boost versus conventional radiotherapy in locally advanced head and neck squamous cell carcinoma: a prospective study. J Evol Med Dent Sci. 2019 Mar.
- Katariya S, Verma M, Jain A, Singh AP. Reirradiation using conventional radiotherapy for recurrent malignant disease: institutional outcomes. J Evol Med Dent Sci. 2019 Jan.
- Tomar N, Iyer M, Jain A, Singh AP. Microvascular free flap reconstruction in head and neck cancers: analysis of 200 cases. Int J Med Oral Res. 2018.
- Tomar N, Iyer M, Jain A, Goyal N. Cancer incidence in tobacco chewers and smokers: an epidemiological study. 2018.
Case Reports / Literature Reviews
- Goel V, Jain A, et al. Between a rock and a hard place: papillary renal cell carcinoma with synchronous lung adenocarcinoma. Onco Critical Care. 2025 Sep.
- Goel V, Basu DA, Jain A, et al. Non-gestational choriocarcinoma in postmenopausal period: a case report. BMJ Case Rep. 2025 Dec.
- Jain A, Soni S, Goel V, Singh S, Goyal V. Cardiac metastases: an unusual site for colon cancer metastases. Int J Clin Stud Med Case Rep. 2024 Oct.
- Jain A, Koyyala VP, Narayan S, Jaju A. Hyper-progressive disease during immune checkpoint therapy. Indian J Med Paediatr Oncol. 2022 Apr.
- Narayan S, Talwar V, Redhu P, Goel V, Jain A, Soni S. Serpentine supravenous hyperpigmentation: “Badge of Courage” in cancer. Gulf J Oncol. 2022;40:83–87.
- Soni S, Jain A, et al. Hair depigmentation with pazopanib: a case report. Indian J Skin Allergy. 2024 Feb.
- Mathighatta SS, Jain A, Goyal S, Goyal J. Autoimmune hemolytic anemia in testicular NSGCT: a rare paraneoplastic syndrome. Indian Cancer Awareness J. 2023 May.
Book Chapters
My Reports
RGCIRC, Niti Bagh
